• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过被动转移针对不同血凝素分子的呼吸道IgA抗体对甲型流感病毒感染的交叉保护作用。

Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.

作者信息

Tamura S, Funato H, Hirabayashi Y, Suzuki Y, Nagamine T, Aizawa C, Kurata T

机构信息

Department of Pathology, National Institute of Health, Tokyo, Japan.

出版信息

Eur J Immunol. 1991 Jun;21(6):1337-44. doi: 10.1002/eji.1830210602.

DOI:10.1002/eji.1830210602
PMID:1646112
Abstract

Mice that were intranasally immunized with different influenza A virus hemagglutinins (HA), derived from PR8 (H1N1), A/Yamagata (H1N1) or A/Fukuoka (H3N2) virus, together with cholera toxin B subunit as an adjuvant, were examined for protection against PR8 infection; PR8 HA and A/Yamagata HA immunization conferred complete protection, while A/Fukuoka HA immunization failed to confer protection. In parallel with protection, PR8 HA-, A/Yamagata HA-, and A/Fukuoka HA-immunized mice produced a high, a moderate and a low level of PR8 HA-reactive IgA in the respiratory tract, respectively. These IgA antibodies were not only higher in content in the nasal secretions, but also more cross-reactive than IgG. The purified IgA antibodies from respiratory tract washings of PR8 HA-immunized mice, which contained the HA-specific IgA corresponding to the amount detected in the nasal wash, were able to protect mice from PR8 challenge when transferred to the respiratory tract of naive mice. The transfer of IgA from A/Yamagata HA-immunized mice also afforded cross-protection against PR8 infection, whereas the IgA from A/Fukuoka HA-immunized mice failed to provide protection. The ability of transferred IgA to prevent viral infection was dependent on the amount of HA-reactive IgA remaining in the respiratory tract of the host at the time of infection. These experiments directly demonstrate that IgA antibodies to influenza A virus HA by themselves play a pivotal role in defence not only against homologous virus infection, but also against heterologous drift virus infection at the respiratory mucosa, the portal of entry for the viruses.

摘要

将源自PR8(H1N1)、A/山形(H1N1)或A/福冈(H3N2)病毒的不同甲型流感病毒血凝素(HA)与霍乱毒素B亚基作为佐剂一起经鼻内免疫小鼠后,检测其对PR8感染的保护作用;PR8 HA和A/山形HA免疫可提供完全保护,而A/福冈HA免疫未能提供保护。与保护作用平行的是,经PR8 HA、A/山形HA和A/福冈HA免疫的小鼠在呼吸道中分别产生了高水平、中等水平和低水平的PR8 HA反应性IgA。这些IgA抗体不仅在鼻分泌物中的含量更高,而且比IgG具有更强的交叉反应性。从经PR8 HA免疫的小鼠呼吸道冲洗液中纯化的IgA抗体,其含有的HA特异性IgA与鼻冲洗液中检测到的量相当,当转移到未免疫小鼠的呼吸道时,能够保护小鼠免受PR8攻击。从经A/山形HA免疫的小鼠转移的IgA也能提供针对PR8感染的交叉保护,而从经A/福冈HA免疫的小鼠转移的IgA则不能提供保护。转移的IgA预防病毒感染的能力取决于感染时宿主呼吸道中残留的HA反应性IgA的量。这些实验直接证明,针对甲型流感病毒HA的IgA抗体自身不仅在抵御同源病毒感染中起关键作用,而且在呼吸道黏膜(病毒的进入门户)抵御异源漂移病毒感染中也起关键作用。

相似文献

1
Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.通过被动转移针对不同血凝素分子的呼吸道IgA抗体对甲型流感病毒感染的交叉保护作用。
Eur J Immunol. 1991 Jun;21(6):1337-44. doi: 10.1002/eji.1830210602.
2
Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine.流感血凝素疫苗经鼻接种对皮下接种具有更强的交叉保护作用。
Eur J Immunol. 1992 Feb;22(2):477-81. doi: 10.1002/eji.1830220228.
3
Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.用霍乱毒素B亚基经鼻接种三价灭活疫苗所提供的针对流感病毒感染的交叉保护作用。
J Immunol. 1992 Aug 1;149(3):981-8.
4
Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant.以几丁质微粒作为佐剂经鼻内给予血凝素疫苗预防流感病毒感染
J Med Virol. 2005 Jan;75(1):130-6. doi: 10.1002/jmv.20247.
5
Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza.呼吸道血凝素特异性IgA抗体在预防流感中的功能作用。
Vaccine. 1990 Oct;8(5):479-85. doi: 10.1016/0264-410x(90)90250-p.
6
Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.以重组霍乱毒素B亚基作为黏膜佐剂经鼻腔免疫流感病毒血凝素对小鼠的保护作用
Microbiol Immunol. 2008 Feb;52(2):55-63. doi: 10.1111/j.1348-0421.2008.00010.x.
7
Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.合成双链RNA聚肌苷酸胞嘧啶核苷酸(poly(I:C))与黏膜疫苗联合使用可预防流感病毒感染。
J Virol. 2005 Mar;79(5):2910-9. doi: 10.1128/JVI.79.5.2910-2919.2005.
8
Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.以文蛤微粒(SMP)为佐剂的鼻内疫苗对流感病毒感染的防护作用。
J Med Virol. 2006 Jul;78(7):954-63. doi: 10.1002/jmv.20647.
9
Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus.分泌型IgA抗体对不同株乙型流感病毒感染提供交叉保护。
J Med Virol. 2004 Oct;74(2):328-35. doi: 10.1002/jmv.20173.
10
Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity.经呼吸道感染甲型流感病毒的小鼠中的交叉保护作用与局部IgA抗体相关,而非血清抗体或细胞毒性T细胞反应性。
Eur J Immunol. 1984 Apr;14(4):350-6. doi: 10.1002/eji.1830140414.

引用本文的文献

1
Calboxyvinyl polymer adjuvant enhances respiratory iga responses through mucosal and systemic administration.羧乙烯基聚合物佐剂通过黏膜和全身给药增强呼吸道IgA反应。
NPJ Vaccines. 2025 Feb 11;10(1):28. doi: 10.1038/s41541-025-01086-0.
2
Intranasal Vaccination with Recombinant TLR2-Active Outer Membrane Vesicles Containing Sequential M2e Epitopes Protects against Lethal Influenza a Challenge.用含有连续M2e表位的重组TLR2激活外膜囊泡进行鼻内接种可抵御致死性甲型流感病毒攻击。
Vaccines (Basel). 2024 Jun 29;12(7):724. doi: 10.3390/vaccines12070724.
3
The immune system of chicken and its response to H9N2 avian influenza virus.
鸡的免疫系统及其对 H9N2 禽流感病毒的反应。
Vet Q. 2023 Dec;43(1):1-14. doi: 10.1080/01652176.2023.2228360.
4
A Dual Adjuvant System for Intranasal Boosting of Local and Systemic Immunity for Influenza Vaccination.一种用于鼻内加强流感疫苗接种的局部和全身免疫的双重佐剂系统。
Vaccines (Basel). 2022 Oct 11;10(10):1694. doi: 10.3390/vaccines10101694.
5
Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.鼻腔接种疫苗诱导针对 SARS-CoV-2 变体的交叉保护分泌型 IgA 抗体,降低肺嗜酸性免疫病理学的潜在风险。
Vaccine. 2022 Sep 29;40(41):5892-5903. doi: 10.1016/j.vaccine.2022.08.049. Epub 2022 Aug 26.
6
A New Grand Challenge in Rhinology: An Intranasal COVID Vaccine.鼻科学的一项新重大挑战:鼻内新冠疫苗
Front Allergy. 2022 May 20;3:881118. doi: 10.3389/falgy.2022.881118. eCollection 2022.
7
The Role of IgA in Chronic Upper Airway Disease: Friend or Foe?IgA在慢性上气道疾病中的作用:益友还是敌人?
Front Allergy. 2022 Mar 9;3:852546. doi: 10.3389/falgy.2022.852546. eCollection 2022.
8
The seven constitutive respiratory defense barriers against SARS-CoV-2 infection.抵抗 SARS-CoV-2 感染的七大固有呼吸道防御屏障。
Rev Soc Bras Med Trop. 2021 Dec 17;54:e04612021. doi: 10.1590/0037-8682-0461-2021. eCollection 2021.
9
Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA.鼻内预刺激诱导局部肺驻留 B 细胞群体分泌保护性黏膜抗病毒 IgA。
Sci Immunol. 2021 Dec 10;6(66):eabj5129. doi: 10.1126/sciimmunol.abj5129.
10
The Interleukin-33-Group 2 Innate Lymphoid Cell Axis Represents a Potential Adjuvant Target To Increase the Cross-Protective Efficacy of Influenza Vaccine.白细胞介素-33-组 2 先天淋巴细胞轴代表了增加流感疫苗交叉保护效力的潜在佐剂靶点。
J Virol. 2021 Oct 27;95(22):e0059821. doi: 10.1128/JVI.00598-21. Epub 2021 Sep 1.